Sign Out
Pulmonary Toxicity.
Please refer Adverse Reactions for more details.
Use in Pregnancy: Category D.
Gefitinib may cause fetal harm when administered to a pregnant woman.
There are no adequate and well-controlled studies in pregnant women using Gefitinib. If Gefitinib is used during pregnancy or if the patient becomes pregnant while receiving this drug, she should be apprised of the potential hazard to the fetus or potential risk for loss of the pregnancy.
